Compliance

What the rules allow, and what they do not

An educational summary for professional readers. It does not replace legal advice for your jurisdiction or your organization.

Regulatory awareness: Rare Medication emphasizes workflows aligned with licensed pharmaceutical distribution, documentation, and import rules applicable to each destination market. Organizations remain responsible for local regulatory compliance, prescribing rules, and institutional governance.
International sourcing principles: Cross-border availability is not automatic. Product registration, wholesaler licensing, export controls, and destination country import rules all affect feasibility. Inquiries are reviewed for fit rather than guaranteed pathways.
Responsible procurement: We avoid consumer pharmacy storefront language. Requests should come from authorized institutional buyers or their delegates, with realistic timelines and clear product identifiers.
Licensed wholesale partners: Where quotations are explored, they are intended to align with authorized distribution models. Fulfillment details depend on product, market, and documentation outcomes.
Country-specific restrictions: Some medicines are subject to additional controls, cold-chain requirements, or national allocation programs. Desk review may decline or defer requests that cannot be supported compliantly.